Identification of an exosomal miRNA-mRNA regulatory network contributing to methotrexate efficacy.

Zhang, Mengmeng; Niu, Zhenmin; Huang, Qiong; Han, Ling; Du, Juan; Liang, Jun; Cheng, Yanwen; Cao, Ruoshui; Yawalkar, Nikhil; Zhang, Zhenghua; Yan, Kexiang (2024). Identification of an exosomal miRNA-mRNA regulatory network contributing to methotrexate efficacy. International immunopharmacology, 135(112280), p. 112280. Elsevier 10.1016/j.intimp.2024.112280

[img] Text
1-s2.0-S1567576924008002-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB)

OBJECTIVE

Methotrexate (MTX) is an economic and effective medicine treatment for psoriasis. Extracellular vesicle (EV) miRNA biomarkers related to its efficiency have been identified in various diseases. Whether certain miRNA profiles are associated with psoriasis treatment is unknown. In order to determine specific miRNA biomarkers for MTX effectiveness prediction and the severity of psoriasis, our study looked at the variations in circulating EV miRNA profiles before and after MTX therapy.

METHODS

Plasma EV isolation and next-generation sequencing were performed to identify differentially expressed EV miRNAs between GRs (n = 14) and NRs (n = 6). Univariate and multiple linear regression analyses were performed to evaluate the correlation between PASI scores and miRNA expression levels.

RESULTS

15 miRNAs out of a total profile of 443 miRNAs were substantially different between GRs and NRs at baseline, 4 of them (miR-199a-5p, miR-195-5p, miR-196a-5p, and miR-1246) have the potential to distinguish between GRs and NRs [area under the curve (AUC) ≥ 0.70, all P < 0.05]. KEGG pathway analyses revealed differentially expressed miRNAs to potentially target immune-related pathways. SIRT1 was discovered to be a target of miR-199a-5p and involved in MAPK signaling pathway. MiR-191-5p and miR-21-5p expression levels have been discovered to positively correlate with PASI scores[P < 0.05].

CONCLUSION

This pilot investigation found that miR-199a-5p, miR-195-5p, miR-196a-5p, and miR-1246 might be prospective biomarkers to predict the efficacy of MTX, and that miR-191-5p and miR-21-5p were correlated with psoriasis severity. Five of them previously reported to be involved in MAPK signaling pathway, indicating a potential role of MTX in delaying the progression of psoriatic inflammation.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology

UniBE Contributor:

Yawalkar, Nikhil

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1567-5769

Publisher:

Elsevier

Language:

English

Submitter:

Pubmed Import

Date Deposited:

23 May 2024 09:39

Last Modified:

08 Jun 2024 00:16

Publisher DOI:

10.1016/j.intimp.2024.112280

PubMed ID:

38776848

Uncontrolled Keywords:

Biomarkers Psoriasis miRNA

BORIS DOI:

10.48350/197036

URI:

https://boris.unibe.ch/id/eprint/197036

Actions (login required)

Edit item Edit item
Provide Feedback